The effects of naftidrofuryl on local cerebral glucose utilization have been examined in 21 lightly restrained, conscious rats by means of the quantitative autoradiographic 2-deoxyglucose technique, Naftidrofuryl (15,30, and 45 mg/kg, Lp,) did not significantly alter the rate of glucose utilization in any of the 29 gray matter or 4 white matter areas that were examined, Because of the close relationship between energy metabolism and physiological function in the central nervous system, the 2-deoxyglucose (2-DG) method is particularly suitable for mapping of functional neuroanatomical pathways (Sokoloff et al., 1977).
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Recently it has been reported that oral adminis tration of naftidrofuryl modifies cerebral metabo lism, especially as regards glucose catabolism (Meynaud et al., 1973; Meynaud et al., 1975; Cretet, et al., 1978) .
MATERIALS AND METHOD

Animals
The experiments were carried out on normal adult male Sprague-Dawley rats weighing 350-420 g. 
Experimental Procedure
Local cerebral glucose utilization (LCG U) was measured by the method of Sokoloff et al. (1977) .
Rats were anesthetized with halothane (1.5%) and N20 (70%), and polyethylene catheters were inserted in a femoral artery and vein. The animals were then placed in a loose-fitting plaster cast and allowed to recover from the effects of anesthesia for at least 2 h. The drug was injected intraperitoneally in three different doses (15, 30, and 45 mg/kg) 30 or 45 min before the intravenous injection of a pulse of [14C]DG (125 /LCi/kg body weight). During the following 45 min, 13 timed blood samples were drawn; the blood was immedi ately centrifuged and the plasma placed on ice until further analysis. At the end of the 45 min the animals were killed by decapitation, and the brains were removed and frozen in isopentane chilled to -40°C. The brains were then coated with an em bedding medium and stored in a plastic bag at -70°C until they were cut in serial sections of 20 /Lm thickness and prepared for the autoradiography as previously described (Sokoloff et aI., 1977) . The Moreover, the means of the values of 6 areas of cortex ("mean cortex"), 23 gray structures ("mean gray"), and of 4 white ("mean white") were com puted.
Statistical Analysis
LCGU was measured in 33 structures (29 gray and 4 white) in 9 controls and 12 treated animals.
Each structure was analyzed for statistically signifi cant difference from control by the Student t-test.
RESULTS
The physiological variables measured were not significantly different in the experimental animals and controls. The LCGU of the control group was generally lower than the values published in the original report (Sokoloff et aI., 1977) , with a reduc tion up to 30% in the auditory cortex. None of the drug-treated groups showed any sig nificant differences in LCG U from the levels in the controls (Table 1) .
DISCUSSION
The clinical studies previously mentioned need to be confirmed; however, the neurological conditions to which they refer are not likely to be improved by the vasodilator action of the naftidrofuryl, and its useful effect has been widely attributed to its re ported capacity to enhance cellular energy metabo lism. This capacity was claimed essentially on the basis of the observation that the brain concentra tions of gluco�e, ATP, and phosphocreatine are augmented and the lactate concentration decreased in animals treated with the drug, but there is no direct evidence that the drug enhances glucose utili zation in the brain.
Our study shows that naftidrofuryl has no signifi cant effects on glucose utilization in the brain, either as a whole or regionally in normal, awake rats. This observation is confined to the species under study and also to acute administration of 15, 30, and 45 mg/kg of the drug. We noticed at the intermediate dosage a slight, but not statistically significant, increase in LCGU in cerebral structures that was not confirmed at higher doses. It is fair to state, therefore, that with an acute administration of up to 10 -20 times that suggested for clinical' use (i.e., 1-2 mg/kg) , naftidrofuryl is ineffective in al tering local cerebral energy metabolism in normal laboratory rats. This study provides a model by which the metabolic effects of drugs can be studied quantitatively and at a local level in the brain. We just mention, as an example, the studies previously done in animals treated with amphetamine (Wechsler et aI., 1979 ), f3-endorphin (Sakurada et aI., 1978 , and adrenoreceptor blockers (Savaki et aI., 1978) , in which a modification of the LCGU has been clearly shown and measured, circumventing the uncertainties and criticism applicable to a vast amount of controversial information obtained with qualitative or observational techniques. 
